Quatrx Pharmaceuticals, a developer of drugs in the endocrine, metabolic and cardiovascular therapeutic areas, registered for an initial public offering Friday evening. Banc of America and SG Cowen are the joint book runners on the deal. Terms and timing have yet to be announced.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
